Meet our TCR discovery experts at SITC 2022

Meet our TCR discovery experts at SITC 2022

One of our senior scientists in discovery, Juliana Barclay, will be presenting at Society for Immunotherapy of Cancer (SITC) 2022 in Boston this Friday, November 11. Juliana will present on the discovery and development of t-cell receptors for adoptive T-cell therapy...

ImmunoScape’s CEO interviewed by Enpoints

ImmunoScape’s CEO Choon-Peng Ng is featured in Endpoints. Endpoints highlights ImmunoScape’s $14M funding round, our use of machine learning to discover TCR-T cell therapies focused on solid tumors, and our progress toward the clinic. You can read the full...

ImmunoScape To Present at the 7th Annual CAR-TCR Summit

ImmunoScape To Present at the 7th Annual CAR-TCR Summit San Diego, California and Singapore – September 14, 2022 – ImmunoScape, a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR-T-cell therapeutics, today announced...
TCR-based Therapies for Solid Tumors Summit

TCR-based Therapies for Solid Tumors Summit

Come see us at TCR-based Therapies for Solid Tumors Summit 6/27 – 6/29 in Boston Katja Fink, PhD, Msc MOT Senior Director of Discovery Katja be presenting on “Discovery of TCRs targeting novel antigens using Deep Immunomics”.
FOCIS 2022

FOCIS 2022

Come see us at FOCIS 6/21 – 6/26 in San Francisco, CA Katja Fink, PhD, Msc MOT Senior Director of Discovery Tuesday June 21, 2022 from 6:15 PM – 7:45 PM Poster Number: Tu80 Katja will be presenting a poster on “Discovery of T cell receptors for Adoptive T...
BIO 2022

BIO 2022

Come see us at BIO 2022 6/13 – 6/16 in San Diego, CA Come meet ImmunoScape at BIO 2022 to learn about the discovery and development of novel T Cell Receptor-based therapeutics in solid tumor oncology using our Deep Immunomics platform....